CLICKSEQ
LIVE

Serial Number

98035641

Owner

ClickSeq Technologies, LLC

Attorney

Marina A. Lewis

Filing Date

Jun 9, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CLICKSEQ Trademark

Serial Number: 98035641

CLICKSEQ is a trademark filed by ClickSeq Technologies, LLC on June 9, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ClickSeq Technologies, LLC (2 trademarks)

2200 MARKET ST STE 604
GALVESTON, TX 775501532

Entity Type: 16

Trademark Details

Filing Date

June 9, 2023

Registration Date

Not Registered

Published for Opposition

October 1, 2024

Goods & Services

DNA and RNA screening for scientific research purposes; DNA and RNA analysis services for scientific research purposes; DNA and RNA library services, namely, providing DNA and RNA sequencing technology research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Laboratory research services in the fields of DNA sequencing, RNA and DNA analysis, and genetic analysis; Scientific research consulting in the field of genetics; Scientific research in the field of genetics and genetic engineering; Scientific testing services, namely, identification and testing of DNA samples for research purposes; Design and development of computer hardware and software; Software as a service (SAAS) services featuring software that provides information and advice relating to genetics, genetic engineering, biomedical testing, DNA screening, and DNA and RNA analysis; Providing information, advisory and consultancy services in relation to scientific research in the field of genetics, DNA and RNA analysis, and biomedical testing

Reagents for scientific or medical research use and reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for scientific and research use; diagnostic reagents for clinical or medical research laboratory use, other than for medical or veterinary purposes and diagnostic reagent kits consisting primarily of buffers and reagents for clinical or medical research laboratory use, other than for medical or veterinary purposes; reagents for use in medical, genetic, and biotechnology research and reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in the medical research, genetic research, and biotechnology research

Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for medical use; Medical diagnostic reagents for clinical or medical laboratory use and medical diagnostic reagent kits consisting primarily of buffers and reagents for clinical or medical laboratory use

DNA and RNA screening for medical purposes; Medical diagnostic testing and reporting services in the fields of DNA sequencing, RNA and DNA analysis, and genetic analysis; Health assessment services, namely, biomedical assessments; Medical diagnostic services, namely, identification and testing of DNA samples for health care purposes; Providing information, advisory, and consultancy services in relation to medical diagnostic testing and reporting

Filing History

TEAS STATEMENT OF USE RECEIVED
Nov 26, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 28, 2025 EX1G
SOU EXTENSION 1 FILED
May 27, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
May 27, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2024 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 5, 2024 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 5, 2024 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Mar 5, 2024 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Mar 5, 2024 CPEA
ASSIGNED TO EXAMINER
Feb 29, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 13, 2023 NWOS
NEW APPLICATION ENTERED
Jun 13, 2023 NWAP